Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • Resource and Technical Advances
    • Clinical Medicine
    • Reviews
    • Editorials
    • Perspectives
    • Top read articles
  • JCI This Month
    • Current issue
    • Past issues

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Editorials
  • Viewpoint
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Transfers
  • Advertising
  • Job board
  • Contact
IgV somatic mutation of human anti–SARS-CoV-2 monoclonal antibodies governs neutralization and breadth of reactivity
Mayara Garcia de Mattos Barbosa, … , Jeffrey L. Platt, Marilia Cascalho
Mayara Garcia de Mattos Barbosa, … , Jeffrey L. Platt, Marilia Cascalho
Published March 26, 2021
Citation Information: JCI Insight. 2021;6(9):e147386. https://doi.org/10.1172/jci.insight.147386.
View: Text | PDF
Research Article COVID-19 Immunology

IgV somatic mutation of human anti–SARS-CoV-2 monoclonal antibodies governs neutralization and breadth of reactivity

  • Text
  • PDF
Abstract

Abs that neutralize SARS-CoV-2 are thought to provide the most immediate and effective treatment for those severely afflicted by this virus. Because coronavirus potentially diversifies by mutation, broadly neutralizing Abs are especially sought. Here, we report a possibly novel approach to rapid generation of potent broadly neutralizing human anti–SARS-CoV-2 Abs. We isolated SARS-CoV-2 spike protein–specific memory B cells by panning from the blood of convalescent subjects after infection with SARS-CoV-2 and sequenced and expressed Ig genes from individual B cells as human mAbs. All of 43 human mAbs generated in this way neutralized SARS-CoV-2. Eighteen of the forty-three human mAbs exhibited half-maximal inhibitory concentrations (IC50) of 6.7 × 10–12 M to 6.7 × 10–15 M for spike-pseudotyped virus. Seven of the human mAbs also neutralized (with IC50 < 6.7 × 10–12 M) viruses pseudotyped with mutant spike proteins (including receptor-binding domain mutants and the S1 C-terminal D614G mutant). Neutralization of the Wuhan Hu-1 founder strain and of some variants decreased when coding sequences were reverted to germline, suggesting that potency of neutralization was acquired by somatic hypermutation and selection of B cells. These results indicate that infection with SARS-CoV-2 evokes high-affinity B cell responses, some products of which are broadly neutralizing and others highly strain specific. We also identify variants that would potentially resist immunity evoked by infection with the Wuhan Hu-1 founder strain or by vaccines developed with products of that strain, suggesting evolutionary courses that SARS-CoV-2 could take.

Authors

Mayara Garcia de Mattos Barbosa, Hui Liu, Daniel Huynh, Greg Shelley, Evan T. Keller, Brian T. Emmer, Emily Sherman, David Ginsburg, Andrew A. Kennedy, Andrew W. Tai, Christiane Wobus, Carmen Mirabeli, Thomas M. Lanigan, Milagros Samaniego, Wenzhao Meng, Aaron M. Rosenfeld, Eline T. Luning Prak, Jeffrey L. Platt, Marilia Cascalho

×

Figure 2

Comparison of the spike-specific VH repertoire and the VH repertoire in the blood.

Options: View larger image (or click on image) Download as PowerPoint
Comparison of the spike-specific VH repertoire and the VH repertoire in ...
IgH sequences were obtained from nonpanned blood B cells by NGS and from spike-panned B cells, as explained in the legend of Figure 1. (A) Number of clones using the top 50 most frequent VH genes in spike-specific clones and in all clones found in the blood. Each column indicates a VH gene, blue bars indicate the frequency of the given VH (by clone) in the blood, and the oranges bar indicate the frequency among spike-specific clones. (B) Fold change of VH gene frequencies in spike-enriched Ig clones as compared with VH gene frequencies in the blood. The height of each bar indicates the ratio of VH gene usage of spike-specific clones to that of other clones in the blood with the same VH. Red indicates a higher frequency in spike-binding clones and blue indicates lower frequency in spike-binding blood clones

Copyright © 2023 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts